The Global Dilated Cardiomyopathy Therapeutic Market estimated at US$304.5 Million in the year 2020, is projected to reach a revised size of US$411.6 Million by 2028, growing at a CAGR of 4% over the forecast period 2022-2028. Dilated cardiomyopathy is an umbrella term for heart muscle disease and is considered a fatal heart disorder. It […]